Dr. Brittney Harrington is an emerging leader in ovarian cancer research, with over 10 years of experience in identifying and investigating therapeutic targets for the disease. After completing her PhD at the University of Queensland in 2016, Dr. Harrington did her postdoctoral research at the prestigious National Cancer Institute in the United States. Dr. Harrington returned to Australia in late 2023, leading research on predictive gene expression signatures for chemotherapy response in ovarian cancers, in Professor Susan Ramus’ Molecular Oncology research group at UNSW. Concurrently, Dr. Harrington leads an independent research project investigating metabolic enzyme activity in the ovarian tumour microenvironment in advanced pre-clinical models.